C
CorMedix Inc. CRMD
$8.13 -$0.05-0.61% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2026 03/31/2026 12/31/2025 09/30/2025 06/30/2025
Net Income 187.17M 181.01M 163.06M 162.50M 51.16M
Total Depreciation and Amortization 35.31M 24.93M 14.55M 4.25M 536.30K
Total Amortization of Deferred Charges 398.00K 398.00K 398.00K -- --
Total Other Non-Cash Items 22.38M 12.19M -10.22M -48.22M 8.89M
Change in Net Operating Assets 8.68M -20.84M 7.27M -43.56M -30.12M
Cash from Operations 253.94M 197.69M 175.05M 74.97M 30.46M
Capital Expenditure -3.52M -2.98M -2.26M -549.90K -53.90K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -308.51M -308.51M -308.51M -310.00M --
Divestitures -- -- -- -- --
Other Investing Activities 26.41M 6.22M 2.34M -1.48M -14.34M
Cash from Investing -285.62M -305.27M -308.43M -312.03M -14.39M
Total Debt Issued 150.00M 150.00M 150.00M 150.00M --
Total Debt Repaid -500.00K -323.00K -188.00K -49.20K --
Issuance of Common Stock 7.36M 90.61M 96.55M 103.27M 116.01M
Repurchase of Common Stock -19.86M -13.59M -1.99M -1.78M -1.32M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -7.05M -6.44M -5.92M -282.40K --
Cash from Financing 129.95M 220.26M 238.45M 251.15M 114.70M
Foreign Exchange rate Adjustments -1.00K 0.00 0.00 -200.00 -100.00
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 98.27M 112.68M 105.07M 14.09M 130.77M